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Do Antibiotic Impregnated Calcium Sulphate Beads Improve the Healing of Neuropathic Foot 
Ulcers with Osteomyelitis Undergoing Surgical Debridement? 
 
Abstract 
Background:  Neuropathic foot ulcers are common and difficult to treat.  Calcium sulphate has been 
used for antibiotic delivery with success in treating osteomyelitis.  Recent case series suggest 
success in treating osteomyelitis of the foot with a mean time to healing of 4 months, however there 
are few studies with a control group for comparison.  This study aimed to determine if antibiotic 
impregnated CAS beads improved the healing of neuropathic foot ulcers with proven osteomyelitis 
undergoing surgical debridement. 
Methods:  A consecutive retrospective cohort study of 50 patients undergoing surgical debridement of 
neuropathic foot ulcers for osteomyelitis was performed.  Exclusion criteria were amputations and 
microbiology findings inconsistent with osteomyelitis.  Patients were analysed comparing one group 
having sharp surgical debridement (SD) and another having debridement and implantation of calcium 
sulphate (CAS) impregnated with vancomycin and gentamicin. 
Results: 42 eligible patients after exclusions; 29 in the CAS group and 13 in the SD group.  In the SD 
group the mean time to healing was 5.8 months (2 to 9 months), and in the CAS group it was 5.5 
months (2 to 13 months).  There was no significant difference in ulcer healing (p=0.81), time to 
healing (p=0.79), re-operation rate (p=0.51), length of stay (p=0.74), or mortality (p=0.13) between the 
two groups. 
Conclusions:  Ulcer healing in patients treated with antibiotic impregnated calcium sulphate beads 
was not significantly improved.  Healing rates in both groups were similar to those in the recent 
literature.  Sharp surgical debridement alone may be as effective as supplementation with local 
antibiotics in a bioabsorbable carrier. 
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Introduction 
The prevalence of diabetes in the United Kingdom is 3.7 million people as of November 20171 and 
diabetic foot ulcers are a common problem with a global prevalence of 6.3%2.  This is in part due to 
approximately 50% of diabetic patients being diagnosed with peripheral neuropathy with loss of 
protective sensation due to micro vascular damage3.  The lifetime risk of a foot ulcer is estimated at 
10% in this population with an estimated 70% 5 year risk of amputation and 50% 5 year risk of death4.  
Foot ulcers are difficult to heal and carry a high recurrence rate5.   
 
The use of antibiotics within a bioabsorbable carrier has been demonstrated to reduce dead space, 
improve local antibiotic delivery to tissues delivering higher concentrations to the wound6 and to 
eradicate and prevent bacterial biofilms6,7.  Historically polymethyl methacrylate (PMMA) cement 
beads have been used, with the disadvantage of the need for a second procedure to remove them8.    
 
Stimulan® (Biocomposites Ltd, Keele, UK) is a bioabsorbable calcium sulphate (CAS) product, which 
is prepared at the time of surgery and can be mixed with chosen antibiotics.  In vitro studies have 
demonstrated that antibiotic elution is effective over 40 days9-11.  A recent study found local 
concentrations above the minimum inhibitory concentration for Staphylococci (4mg/l) 4 weeks after 
treatment for hip joint infection8.  Recent studies have reported success treating tibial and femoral 
osteomyelitis9-11. 
 
There are few published studies on the outcomes of the use of bioabsorbable antibiotic impregnated 
CAS beads in the neuropathic foot.  Several studies have been performed without any comparative 
control group treated without augmentation of surgical treatment with CAS beads.  One case report of 
incision and drainage for forefoot osteomyelitis with packing of the wound with vancomycin and 
gentamicin impregnated CAS beads found the ulcer healed in 4 months12.  One 12 patient case series 
concluded CAS beads to be effective in the treatment of calcaneal osteomyelitis when combined with 
hydroxyapatite with a mean time to healing of 4 months13.  A large case series of 337 diabetic patients 
over 5 years concluded success in the treatment of osteomyelitis with 86% ultimately healing however 
the time to healing was not reported14.  A 20 patient series of forefoot ulcers treated with gentamicin 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  3 
and vancomycin impregnated CAS beads and closed primarily found a median healing time of 5 
weeks15.   
 
One comparative case series was found which included 60 cases of transmetatarsal ampuation for 
diabetic forefoot ulcers with failed non operative management.  The use of tobramycin impregnated 
CAS beads resulted no difference in length of stay, time to a dry wound or time to healing when 
compared to amputation alone16.  Additionally a 46 patient series found improved average healing 
time for CAS beads (4 months) when compared to gentamycin impregnated PMMA beads (6 
months)17. 
 
A literature search revealed no study directly comparing the outcomes of the use of CAS in 
osteomyelitis of the foot in neuropathic ulcers when compared to surgical debridement (excluding 
amputation), therefore antibiotic impregnated CAS beads have not been proven more effective than 
surgical debridement.  A local audit within our unit demonstrated that patients treated with amputation 
for foot ulcer all healed within 2 weeks and had amputation through healthy tissue far from the ulcer 
which grew no organism on microbiological culture.  Surgical wounds which are unable to be 
surgically closed by definition take longer to heal as they must do so by granulation and were the 
subject of this study. 
 
This study aims to determine if antibiotic impregnated CAS beads improved the healing of 
neuropathic foot ulcers with proven osteomyelitis undergoing surgical debridement when compared to 
surgical debridement alone. 
 
Methods 
Study design and study population 
A retrospective cohort study was performed on a consecutive group of 50 patients undergoing foot 
ulcer debridement.  Inclusion criteria were both medical inpatients and outpatients attending our unit 
with deep ulcers penetrating to bone.  Patients were managed by a multidisciplinary team including an 
orthopaedic surgeon (foot and ankle consultant), a specialist nurse, an occupational therapist and a 
consultant physician (consultant in diabetes and endocrinology).  A diagnosis of neuropathy was 
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made by the inability to perceive the 10g of force a 5.07 Semmes-Weinstein monofilament.  Both 
diabetic and non-diabetic patients were included.  Exclusion criteria were amputations and those 
where no microbiological culture of organisms occurred from tissue samples taken at the time of the 
surgical debridement. 
 
Procedure 
A consecutive series of 50 patients were identified from operating theatre records.  A retrospective 
analysis of medical and operative records was performed. 
 
Outcome measures 
Data was extracted for whether the ulcer ultimately healed or did not heal, whether the ulcer was 
active at 6 months, if further surgery was performed at any point within the study period, time to 
healing, length of stay and if the patient was alive at 6 months.  
 
Ulcers were graded using the Sinbad (Site, Ischaemia, Neuropathy, Bacterial infection, Area and 
Depth) score18, which is a standardised system recommended by the National Institute of Clinical 
Excellence (NICE)4.  The range of scores is 0 to a maximum of 6, with a higher score indicating a 
more severe foot ulcer.  Midfoot and hindfoot ulcers score higher than forefoot ulcers; ischaemia is 
defined is defined as absence of palpable pedal pulses; neuropathy is defined as loss of protective 
sensation; ulcer area is divided into greater or less than 1cm2; depth is divided into ulcers superficial 
to subcutaneous tissues and those deep reaching muscle, tendon or bone. 
 
Surgical Procedure 
Patients were positioned on the operating table without the use of a tourniquet in most cases.  The 
skin was prepared using povidone iodine and extremity draping.  In all cases a surgical debridement 
was performed of all infected and non-viable tissue with multiple bony and soft tissue samples taken 
using separate sterile instruments to avoid cross contamination. The ulcer was then thoroughly 
lavaged using 0.9% saline.  Those receiving CAS beads received these based on availability and not 
based on patient or ulcer characteristics.  There was no randomisation.  In the cases where CAS 
beads were used, following the surgical debridement, 5cc of CAS was mixed with 1gram of 
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vancomycin and 160mg of gentamicin.  3mm beads were prepared and packed into the clean bed of 
the ulcer.  In all patients the wound was then left open and either dressed with non-adhesive silicone 
dressings or gauze swabs and bandages.  Systemic antibiotics were used following discussion with a 
consultant microbiologist based on organism growth and antibiotic sensitivities from operative 
samples and clinical features.  Patients who underwent repeat debridement had the same procedure 
repeated.  Any existing CAS beads from a previous procedure were irrigated and debrided from any 
wounds where sufficient time had not elapsed for them to dissolve. 
 
Ethical approval 
This research was registered locally as a service evaluation. 
 
Statistical analysis 
Statistical analysis was performed using SPSS version 2319.  Patients were analysed in two groups; 
group A had a sharp surgical debridement (SD) alone, group B had a debridement followed by 
packing of CAS beads into the wound.  Categorical outcomes (ulcer healed by the end of the study, 
active ulcer at 6 months, alive at 6 months, further surgery performed) were compared using a Chi 
square test.  Time to healing was compared using a t-test as the data was normally distributed.  
Length of stay and duration of antibiotics were compared using the Mann-Whitney U test, as the data 
was not normally distributed.  A correlation analysis was performed to determine if there was a 
relationship between length of ulcer duration and time to healing. 
 
Results 
A 50 patient consecutive series from December 2015 to May 2016 was identified.  8 patients were 
excluded (5 simple toe amputations and 3 cases of no osteomyelitis found and no growth on culture 
of specimens).  All excluded cased healed within 2 weeks.  The remaining eligible patient group 
numbered 42; 13 in the SD group and 29 in the CAS group (Figure1).  Both groups had similar 
features with no significant differences including age, age of ulcer at presentation and severity of ulcer 
as assessed by Sinbad score (Table1).  37 of the 42 patients were diabetic (12 of 13 in the SD group 
and 25 of 29 in the CAS group).  Patients who were not diabetic numbered 1 in the SD group and 4 in 
the CAS group.  The cause of their neuropathic foot was renal failure and transplant in one patient 
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and 4 patients suffering from Charcot-Marie-Tooth hereditary sensory and motor neuropathy.  The 
duration of antibiotic treatment was a median 6 weeks in both groups (IQR 6-12 weeks for the CAS 
group and 2-6 weeks in the SD group), P=0.07.  All patients received systemic antibiotics. 
 
There were no significant differences in any of the outcome measures (Table2, Figure2, Figure3).  
The proportion of patient healed by 12 months was 76.9% in the SD group and 72.4% in the CAS 
group (p=0.81).  The proportion of active ulcers at 6 months was 53.8% in the SD group and 48.3% in 
the CAS group (p=0.74).  The proportion alive at 6 months was 92.3% in the SD group and 100% in 
the CAS group (p=0.13).  Further surgery was performed in 30.8% of the SD group and 58.6% of the 
SD group (p=0.51).  Time to healing was mean 5.8 months in the SD group and 5.5 months in the 
CAS group (p=0.79).  Length of stay was median 16 days in the SD group and 10 days in the CAS 
group (p=0.74). 
 
The most common organisms grown were Gram stain positive bacteria, usually Staphylococcus 
aureus.  Similar organisms were grown from both patient groups (Figure4). 
 
A subgroup analysis revealed no differences in outcome measures comparing surgeon grade 
(consultant versus registrar), use of pulsed lavage versus washout using syringe and intravenous 
giving set and whether the organisms were sensitive to vancomycin or not.  Duration of ulcer at 
presentation did not correlate with time to healing (P=0.980, R=-0.005). 
 
There was one death in the SD group, which was unrelated to the foot ulcer and was not due to 
sepsis.  There were no cases of malignant transformation. 
 
Discussion 
This study aimed to determine if antibiotic impregnated CAS beads improved the healing of 
neuropathic foot ulcers with proven osteomyelitis undergoing surgical debridement when compared to 
surgical debridement alone. 
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We found a mean time to healing of 5.7 months overall with no significant difference between the two 
groups (CAS group mean 5.5 months, range 2-13, SD2.9; SD group mean 5.8 months, range 2-9, 
SD2.4).  This is comparable to the literature with other authors reporting healing in approximately 4 
months13,16,17.  Our population group differed from those in the literature as we included patients with 
vascular deficiency and sepsis and excluded simple forefoot amputations with wounds suitable for 
primary closure.  Wounds were left open to granulate and CAS beads were used to pack the dead 
space within the soft tissue as well as the bony defects.  This may explain the observed slightly longer 
healing time.  The inclusion of patients with vascular insufficiency is significant as in our group 31% 
patients did not have palpable peripheral pulses, reflecting the high incidence of this comorbidity that 
adversely effects outcomes. 
 
Patients received antibiotic treatment individually guided by bacterial growth and antibiotic sensitivity 
from tissue samples taken at the time of debridement.  There was no difference in the duration of 
antibiotics between groups.  There was no difference in the number of patients who had growth of an 
organism from biopsy samples taken following debridement and irrigation in each group. 
 
Although other authors have concluded treatment with antibiotic impregnated CAS to be effective in 
treating infection in the diabetic foot as well as elsewhere in the body, this study represents the first 
comparative study of the outcomes of treatment of infected diabetic foot ulcers that included all 
regions of the foot.  The only other study comparing outcomes found on literature search was a single 
60 patient case series of transmetatarsal ampuations for diabetic forefoot ulcers with failed non 
operative management.  The authors compared tobramycin impregnated CAS beads to amputation 
without CAS beads and found no difference in length of stay, time to a dry wound or time to healing16. 
 
Other studies did not have a comparison group.  One 12 patient case series treating calcaneal 
osteomyelitis combined CAS with hydroxyapatite using a novel technique with a mean time to healing 
of 16 weeks13.  A large case series of 337 diabetic patients over 5 years concluded success in the 
treatment of osteomyelitis with 86% ultimately healing however the time to healing was not reported 
14.  This study excluded patients suffering from peripheral vascular disease, Charcot arthropathy, 
sepsis and inability to offload.  Another 20 patient series of forefoot ulcers treated with gentamicin and 
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vancomycin impregnated CAS beads found a median healing time of 5 weeks only.  However, this 
study included only forefoot ulcers with wounds that all underwent primary closure15.  
 
Within our unit we used CAS with vancomycin and gentamicin supplementation for over 2 years with 
perceived success.  Our results suggest that surgical debridement was as effective.  Interestingly the 
only other study comparing a group treated with CAS and without also found similar outcomes16. 
 
The cost implication of the use of CAS beads is not insignificant.  In our hospital, 5cc of CAS cost 
£260 ($336), 1 gram of vancomycin cost £1.97 ($2.55) and 160mg of gentamicin cost £1.06 ($1.37).  
The total price for treatment in materials alone was therefore £263.03 ($340) in addition to the theatre 
time required to prepare the beads. 
 
Limitations 
This study has some limitations being a small series of retrospectively analysed patients.  In our unit 
gentamicin and vancomycin impregnated CAS beads were being introduced and therefore were often 
used as an adjunct in the treatment of diabetic foot ulcers following surgical debridement when 
available.  There was no randomisation and therefore there is a possibility of selection bias.  The use 
of a consecutive series reduced this bias however resulted in unequal groups with more patients in 
the CAS group.  As we used SINBAD scoring for vascular assessment we used palpation of pedal 
pulses which may have been inaccurate and prone to bias.   
 
Conclusions 
In conclusion, the use of antibiotic impregnated CAS beads in conjunction with surgical debridement 
of neuropathic foot ulcers with osteomyelitis did not result in significantly faster healing, reduced 
length of stay or need for further debridement undergoing surgical debridement.  Further prospective 
investigation with randomised controlled trial is warranted to provide higher level evidence. 
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Tables and Figures 
Table1. Demographics of patients in each group; sharp surgical debridement alone (SD) and those 
treated with debridement followed by antibiotic impregnated calcium sulphate beads (CAS). 
 SD (n=13) CAS (n=29) 
Age (SD) 64.6 (10.2) 62.8 (15.5) 
Age range 51 to 84 36 to 89 
Sex 12 M, 1 F 21 M, 8 F 
Deaths 1 (8%) 0 (0%) 
Malignant change 0 (0%) 0 (0%) 
Age of ulcer at presentation (SD) 9.0 (7.2) 7.3 (7.4) 
Wagner (SD) 2.8 (0.9) 3.5 (1.4) 
Sinbad (SD) 4 (1) 3.4 (1.4) 
Presence of pus 4 (31%) 8 (28%) 
Diabetic (type1, type2) 12 (2, 10) 25 (4, 21) 
Location: Forefoot or midfoot 3 (23%) 18 (62%) 
Location: Hindfoot 10 (77%) 11 (38%) 
Charcot 2 (16%) 5 (18%) 
Insulin 3 (23%) 10 (35%) 
CKD 2 (16%) 7 (24%) 
Vascular insufficiency 4 (31%) 9 (31%) 
Smoker 0 (0%) 3 (10%) 
Transplant 0 (0%) 1 (4%) 
Care home 0 (0%) 2 (7%) 
Surgeon: Registrar 4 (31%) 11 (38%) 
Surgeon: Consultant 9 (69%) 18 (62%) 
Pulsed lavage 6 (46%) 20 (69%) 
Revision case 3 (23%) 6 (21%) 
Joint involved 1 (8%) 9 (31%) 
Weeks of antibiotics weeks (SD) 5.1 (3.1) 7.5 (3.0) 
Sensitive to vancomycin 7 (54%) 26 (100%) 
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Table2. Key outcome measures of patients in each group; sharp surgical debridement alone (SD) and 
those treated with debridement followed by antibiotic impregnated calcium sulphate beads (CAS). 
 
 SD (n=13) CAS (n=29) Test Significance 
Healed by 12 months 10 (76.9%) 21 (72.4%) Chi square p=0.81 
Active ulcer at 6 months 7 (53.8%) 14 (48.3%) Chi square p=0.74 
Alive at 6 months 12 (92.3%) 29 (100%) Chi square p=0.13 
Further surgery performed 4 (30.8%) 17 (58.6%) Chi square p=0.51 
Time to healing (months) (SD) 5.8 (2.4) 5.5 (2.9) T-test p=0.79 
Length of Stay (days) (IQR) 16 (6) 10 (7) Mann-Whitney U  p=0.74 
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Figure1. Patient flowchart 
 
 
 
 
Figure 2. Bar chart of outcomes for patients treated with sharp surgical debridement alone (SD) and 
those treated with debridement followed by antibiotic impregnated calcium sulphate beads (CAS). 
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Figure 3. Box and whisker plot of length of stay (days) and time to healing (months) for patients 
treated with sharp surgical debridement alone (SD) and those treated with debridement followed by 
antibiotic impregnated calcium sulphate beads (CAS).   
 
 
 
 
Figure 4. Bar chart of organisms grown for patients treated with sharp surgical debridement alone 
(SD) and those treated with debridement followed by antibiotic impregnated calcium sulphate beads 
(CAS).   
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